RADX ▼ -5.6% - Radiopharm Theranostics Limited $RADX - Radiopharm Completes Productive End-of-Phase 2 Meeting with U.S. Food and Drug Administration for Pivotal Development Program of RAD101 05-OCT-2026 08:00 AM ET